Febuxostat

  • 1 lab in 1 country
  • Funders: National Science and Technology Council and 2 more
  • Humans1

Associations

1

Frailty

upin humans1HR 1.22

1 study
  1. Febuxostat raises the risk of frailty in humans (HR 1.22, 95% CI 1.01-1.48).

    Humansin nephrology patients versus non-usersmedian follow-up of 3.0 yearsn = 19,389

    Differential associations of febuxostat and allopurinol with incident and worsening frailty risk in nephrology patients

    International journal of medical sciences4 Aug 2026

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 01 in 12 months